Literature DB >> 8018488

Lymphocyte subpopulations, interleukin-2 and interleukin-2 receptor expression in childhood nephrotic syndrome.

S A Hulton1, V Shah, M R Byrne, G Morgan, T M Barratt, M J Dillon.   

Abstract

Abnormal T lymphocyte function and reduced interleukin-2 (IL-2) production have been implicated in the pathogenesis of the nephrotic syndrome (NS). We investigated: (1) lymphocyte subpopulations and expression of IL-2 receptor (IL-2R) on T cells using two-colour flow cytometry, (2) serum IL-2 and (3) the soluble component of IL-2R (sIL-2R) in serum, using enzyme-linked immunosorbent assay, in 38 children with NS. All children, except those in remission, had marked proteinuria. They were divided into groups according to renal pathology: (1) steroid-sensitive NS (SSNS) not receiving prednisolone therapy, (2) SSNS on prednisolone, (3) focal segmental glomerulosclerosis (FSGS), (4) SSNS in remission and not receiving prednisolone therapy, (5) congenital NS (CNS). Results were compared with 26 age-matched controls. Total T lymphocytes (CD3) were reduced in groups 1 and 2; CD4 count was reduced in groups 1-4; CD8 count increased in groups 2 and 3; CD8 and CD19 (B lymphocytes) were significantly reduced in group 5. Increased IL-2R expression (CD25) on CD4 lymphocytes was noted in groups 1, 2 and 3 implying activation of these cells. In patients with SSNS, increased serum sIL-2R was recorded during relapse (1,273 +/- 497 U/l vs. 913 +/- 401 U/l in remission, P < 0.005) but free serum IL-2 was not detectable at any stage. The specific alterations in lymphocyte subpopulations in SSNS and FSGS would imply an involvement of the immune system distinct from that in CNS.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8018488     DOI: 10.1007/bf00865458

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  25 in total

1.  Lymphocyte release of soluble IL-2 receptors in patients with minimal change nephropathy.

Authors:  M Mandreoli; E Beltrandi; M Casadei-Maldini; R Mancini; A Zucchelli; P Zucchelli
Journal:  Clin Nephrol       Date:  1992-04       Impact factor: 0.975

2.  T cell growth factor: parameters of production and a quantitative microassay for activity.

Authors:  S Gillis; M M Ferm; W Ou; K A Smith
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

3.  Lymphocyte subpopulations in minimal change nephrotic syndrome.

Authors:  H O Kerpen; J G Bhat; R Kantor; B Gauthier; K R Rai; R G Schacht; D S Baldwin
Journal:  Clin Immunol Immunopathol       Date:  1979-09

4.  Pathogenesis of lipoid nephrosis: a disorder of T-cell function.

Authors:  R J Shalhoub
Journal:  Lancet       Date:  1974-09-07       Impact factor: 79.321

Review 5.  The soluble interleukin-2 receptor: biology, function, and clinical application.

Authors:  L A Rubin; D L Nelson
Journal:  Ann Intern Med       Date:  1990-10-15       Impact factor: 25.391

6.  Serum soluble interleukin-2 receptor in patients with glomerulonephritis.

Authors:  N Yorioka; A Hirabayashi; K Kanahara; A Takemasa; H Oda; Z H Joarder; M Yamakido
Journal:  Am J Nephrol       Date:  1990       Impact factor: 3.754

7.  A regulatory system for soluble immune response suppressor production in steroid-responsive nephrotic syndrome.

Authors:  H W Schnaper
Journal:  Kidney Int       Date:  1990-07       Impact factor: 10.612

8.  Evaluation of T lymphocyte subpopulations in children with nephrotic syndrome.

Authors:  H G Herrod; F B Stapleton; R L Trouy; S Roy
Journal:  Clin Exp Immunol       Date:  1983-06       Impact factor: 4.330

9.  Alternate-day prednisone therapy and human lymphocyte subpopulations.

Authors:  A S Fauci; D C Dale
Journal:  J Clin Invest       Date:  1975-01       Impact factor: 14.808

10.  Prednisone-induced alterations of circulating human lymphocyte subsets.

Authors:  J D Slade; B Hepburn
Journal:  J Lab Clin Med       Date:  1983-03
View more
  15 in total

1.  T regulatory cell function in idiopathic minimal lesion nephrotic syndrome.

Authors:  Carlos Araya; Leila Diaz; Clive Wasserfall; Mark Atkinson; Wei Mu; Richard Johnson; Eduardo Garin
Journal:  Pediatr Nephrol       Date:  2009-06-03       Impact factor: 3.714

2.  Short courses of daily prednisolone during upper respiratory tract infections reduce relapse frequency in childhood nephrotic syndrome.

Authors:  Asiri S Abeyagunawardena; R S Thalgahagoda; Pathum V Dissanayake; Shamali Abeyagunawardena; Y A Illangasekera; Umeshi I Karunadasa; Richard S Trompeter
Journal:  Pediatr Nephrol       Date:  2017-03-24       Impact factor: 3.714

Review 3.  Pathogenesis of childhood idiopathic nephrotic syndrome: a paradigm shift from T-cells to podocytes.

Authors:  Kazunari Kaneko; Shoji Tsuji; Takahisa Kimata; Tetsuya Kitao; Sohsaku Yamanouchi; Shogo Kato
Journal:  World J Pediatr       Date:  2015-01-28       Impact factor: 2.764

Review 4.  Treatment of steroid sensitive nephrotic syndrome.

Authors:  A S Abeyagunawardena
Journal:  Indian J Pediatr       Date:  2005-09       Impact factor: 1.967

5.  Lymphocyte adenosine deaminase activity in children with idiopathic nephrotic syndrome.

Authors:  Om P Mishra; Jayant Ghosh; Ziledar Ali; Malay Sen; Rajniti Prasad
Journal:  Pediatr Nephrol       Date:  2005-08-13       Impact factor: 3.714

6.  Stem cell mobilization in idiopathic steroid-sensitive nephrotic syndrome.

Authors:  Hélène Lapillonne; Annelaure Leclerc; Tim Ulinski; Laurent Balu; Arnaud Garnier; Nathalie Dereuddre-Bosquet; Hervé Watier; Marie-Hélène Schlageter; Georges Deschênes
Journal:  Pediatr Nephrol       Date:  2008-05-06       Impact factor: 3.714

7.  The concurrent presentation of minimal change nephrotic syndrome and aplastic anemia.

Authors:  Elissa Michele Abrams; Ian W Gibson; Tom David Blydt-Hansen
Journal:  Pediatr Nephrol       Date:  2008-09-25       Impact factor: 3.714

8.  The use of steroid-sparing agents in steroid-sensitive nephrotic syndrome.

Authors:  Asiri S Abeyagunawardena; Michael J Dillon; Lesley Rees; William van't Hoff; Richard S Trompeter
Journal:  Pediatr Nephrol       Date:  2003-07-23       Impact factor: 3.714

9.  T cell CD3 receptor zeta (TCRzeta)-chain expression in children with idiopathic nephrotic syndrome.

Authors:  Diego H Aviles; Matti V Vehaskari; Kirk S Culotta; Jennifer Manning; Augusto C Ochoa; Arnold H Zea
Journal:  Pediatr Nephrol       Date:  2008-12-10       Impact factor: 3.714

Review 10.  The pediatric nephrotic syndrome spectrum: clinical homogeneity and molecular heterogeneity.

Authors:  Asher D Schachter
Journal:  Pediatr Transplant       Date:  2004-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.